FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2883762200> ?p ?o ?g. }

• W2883762200 endingPage "4225" @default.
• W2883762200 startingPage "4214" @default.
• W2883762200 abstract "The electrospun nanofiber-based orally dissolving webs are promising candidates for rapid drug release, which is due to the high surface area to volume ratio of the fibers and the high amorphization efficacy of the fiber formation process. Although the latter is responsible for the physical and/or chemical instability of these systems. The primary aim of the present study was to elucidate how the addition of polysorbate 80 (PS80) and hydroxypropyl-β-cyclodextrin (HP-β-CD) influenced the electrospinning process, the properties, and the behavior of the obtained nanofibers. In order to reveal any subtle changes attributable to the applied excipients, the prepared samples were subjected to several state of the art imaging and solid state characterization techniques at both macroscopic and microscopic levels. Atomic force microscopy (AFM) revealed the viscoelastic nature of the fibrous samples. At relatively low forces mostly elastic deformation was observed, while at higher loads plasticity predominated. The use of polysorbate led to about two times stiffer, less plastic fibers than the addition of cyclodextrin. The 1H–13C nuclear magnetic resonance (NMR) cross-polarization build-up curves pointed out that cyclodextrin acts as an inner, while polysorbate acts as an outer plasticizer and, due to its “liquid-like” behavior, can migrate in the polymer-matrix, which results in the less plastic behavior of this formulation. Positron annihilation lifetime spectroscopy (PALS) measurements also confirmed the enhanced mobility of the polysorbate and the molecular packing enhancer properties of the cyclodextrin. Solid-state methods suggested amorphous precipitation of the active ingredient in the course of the electrospinning process; furthermore, the nature of the amorphous systems was verified by NMR spectroscopy, which revealed that the use of the examined additives enabled the development of a molecularly dispersed systems of different homogeneities. An accelerated stability study was carried out to track physical state related changes of the incorporated drug and the polymeric carrier. Recrystallization of the active ingredient could not be observed, which indicated a large stress tolerance capacity, but time-dependent microstructural changes were seen in the presence of polysorbate. Raman mapping verified homogeneous drug distribution in the nanofibrous orally dissolving webs. The performed dissolution study indicated that the drug dissolution from the fibers was rapid and complete, but the formed stronger interaction in the case of the PVA-CD-MH system resulted in a little bit slower drug release, compared to the PS80 containing formulation. The results obviously show that the complex physicochemical characterization of the polymer-based fibrous delivery systems is of great impact since it enables the better understanding of material properties including the supramolecular interactions of multicomponent systems and consequently the rational design of drug-loaded nanocarriers of required stability." @default.
• W2883762200 created "2018-08-03" @default.
• W2883762200 creator A5005219283 @default.
• W2883762200 creator A5009369647 @default.
• W2883762200 creator A5010497341 @default.
• W2883762200 creator A5024851209 @default.
• W2883762200 creator A5029367698 @default.
• W2883762200 creator A5030678964 @default.
• W2883762200 creator A5036723179 @default.
• W2883762200 creator A5045168723 @default.
• W2883762200 creator A5051655899 @default.
• W2883762200 creator A5056198233 @default.
• W2883762200 creator A5056536573 @default.
• W2883762200 creator A5073904575 @default.
• W2883762200 creator A5090374135 @default.
• W2883762200 creator A5091353806 @default.
• W2883762200 date "2018-07-19" @default.
• W2883762200 modified "2023-10-18" @default.
• W2883762200 title "Microstructural Distinction of Electrospun Nanofibrous Drug Delivery Systems Formulated with Different Excipients" @default.
• W2883762200 cites W1741087533 @default.
• W2883762200 cites W1779749258 @default.
• W2883762200 cites W1965059065 @default.
• W2883762200 cites W1976858788 @default.
• W2883762200 cites W2002488997 @default.
• W2883762200 cites W2010227280 @default.
• W2883762200 cites W2015203678 @default.
• W2883762200 cites W2019985721 @default.
• W2883762200 cites W2022367505 @default.
• W2883762200 cites W2037608532 @default.
• W2883762200 cites W2040432233 @default.
• W2883762200 cites W2041145557 @default.
• W2883762200 cites W2045017212 @default.
• W2883762200 cites W2047007407 @default.
• W2883762200 cites W2047843812 @default.
• W2883762200 cites W2049686820 @default.
• W2883762200 cites W2053857863 @default.
• W2883762200 cites W2067895395 @default.
• W2883762200 cites W2067899925 @default.
• W2883762200 cites W2069174472 @default.
• W2883762200 cites W2070332894 @default.
• W2883762200 cites W2074266529 @default.
• W2883762200 cites W2077255322 @default.
• W2883762200 cites W2117901105 @default.
• W2883762200 cites W2127733013 @default.
• W2883762200 cites W2142427113 @default.
• W2883762200 cites W2148820466 @default.
• W2883762200 cites W2182355532 @default.
• W2883762200 cites W2193245378 @default.
• W2883762200 cites W2194085886 @default.
• W2883762200 cites W2211313736 @default.
• W2883762200 cites W2246756058 @default.
• W2883762200 cites W2253675932 @default.
• W2883762200 cites W2289400943 @default.
• W2883762200 cites W2517133976 @default.
• W2883762200 cites W2748417965 @default.
• W2883762200 doi "https://doi.org/10.1021/acs.molpharmaceut.8b00646" @default.
• W2883762200 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30024759" @default.
• W2883762200 hasPublicationYear "2018" @default.
• W2883762200 type Work @default.
• W2883762200 sameAs 2883762200 @default.
• W2883762200 citedByCount "24" @default.
• W2883762200 countsByYear W28837622002018 @default.
• W2883762200 countsByYear W28837622002019 @default.
• W2883762200 countsByYear W28837622002020 @default.
• W2883762200 countsByYear W28837622002021 @default.
• W2883762200 countsByYear W28837622002022 @default.
• W2883762200 countsByYear W28837622002023 @default.
• W2883762200 crossrefType "journal-article" @default.
• W2883762200 hasAuthorship W2883762200A5005219283 @default.
• W2883762200 hasAuthorship W2883762200A5009369647 @default.
• W2883762200 hasAuthorship W2883762200A5010497341 @default.
• W2883762200 hasAuthorship W2883762200A5024851209 @default.
• W2883762200 hasAuthorship W2883762200A5029367698 @default.
• W2883762200 hasAuthorship W2883762200A5030678964 @default.
• W2883762200 hasAuthorship W2883762200A5036723179 @default.
• W2883762200 hasAuthorship W2883762200A5045168723 @default.
• W2883762200 hasAuthorship W2883762200A5051655899 @default.
• W2883762200 hasAuthorship W2883762200A5056198233 @default.
• W2883762200 hasAuthorship W2883762200A5056536573 @default.
• W2883762200 hasAuthorship W2883762200A5073904575 @default.
• W2883762200 hasAuthorship W2883762200A5090374135 @default.
• W2883762200 hasAuthorship W2883762200A5091353806 @default.
• W2883762200 hasConcept C121332964 @default.
• W2883762200 hasConcept C127413603 @default.
• W2883762200 hasConcept C144796933 @default.
• W2883762200 hasConcept C147120987 @default.
• W2883762200 hasConcept C159985019 @default.
• W2883762200 hasConcept C171250308 @default.
• W2883762200 hasConcept C178790620 @default.
• W2883762200 hasConcept C185592680 @default.
• W2883762200 hasConcept C192562407 @default.
• W2883762200 hasConcept C202100949 @default.
• W2883762200 hasConcept C2777897440 @default.
• W2883762200 hasConcept C2778551929 @default.
• W2883762200 hasConcept C2778711141 @default.
• W2883762200 hasConcept C2779820397 @default.
• W2883762200 hasConcept C2985595821 @default.
• W2883762200 hasConcept C42360764 @default.

• next